Corporate Profile
 
 
  
 
 
 


ALAPIS S.A.
Facilities

Where technology meets man

Atalanti - Detergents
The Atalanti plant produces products for household use. The plant has a surface area of 16,250 m2, is one of the most modern and well equipped detergent production plants in Greece and one of the largest in Europe, with storage tanks of 10,000 m3, and continuous inspections that ensure certification to ISO 9002 international standards.
The annual production capacity of the Atalanti facilities is 100,000 tons of powder detergent, 100,000 tons of liquid detergent and 25,000 tons of raw materials.

Thessalonica - Detergents
The Thessalonica plant has a surface area of 12,135 m2. It mainly produces detergents for professional use. Its annual production capacity is 60,000 tons of chemical raw materials and liquid detergents. The Thessalonica facilities have a storage capacity of 1,000 m3 intended for raw materials and semi-ready products, giving Alapis a significant advantage with regard to expanding its activities and entering new markets.
The Thessalonica plant has received ISO 14000 certification for ecological waste management, and the ECOLABEL certificate by the Hellenic Ministry for the Environment, Physical Planning & Public Works that concerns ecological products that have the "green daisy" label.

Bulgaria, Sofia - Detergents
The Sofia plant has production facilities with an annual capacity of 50,000 tons of detergent powder and 50,000 tons of liquid detergent.

Aspropirgos, Attica - Veterinary Pharmaceuticals and Nutritional Supplements
The Aspropirgos plant has state-of-the-art production lines for manufacturing veterinary pharmaceuticals and nutritional supplements, in a privately-owned area of 25,500 m2. Procedure flexibility and the vast number of production lines give Alapis the ability to offer swift solutions, tailor-made to the specific needs of its associates, without compromising high product quality. The technologically advanced facilities of Aspropirgos provide excellent services and products, being certified according to GVCP and GLP quality standards. At the same time, the Aspropirgos Research and Development Department, with its experienced and specialised staff, gives Alapis an additional competitive advantage with regard to the development of new generic pharmaceuticals.









   
 
 
Visit:   www.capitallink.com  |  www.capitallinkcyprus.com  |  www.capitallinkrussia.com
www.closedendfundforum.com  |  www.capitallinkforum.com  |  www.irprofiles.com


©  Copyright 1996-2010. Capital Link, Inc. All rights reserved.

Disclaimer & Terms of Use. The information herein is not an offer to buy or sell any kind of securities nor does it constitute investment advice of any kind. Capital Link does not represent or warrant the accuracy of the information in this site. The user of the site acknowledges that he/she accesses the information at his/her own risk and cannot hold Capital Link liable for any matter in any way. Please read full disclaimer and terms of use.